Logo image of MND.CA

MANDALAY RESOURCES CORP (MND.CA) Stock Fundamental Analysis

TSX:MND - Toronto Stock Exchange - CA5625684025 - Common Stock - Currency: CAD

4.6  +0.06 (+1.32%)

Fundamental Rating

7

MND gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 805 industry peers in the Metals & Mining industry. MND has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MND is valued quite cheap, while showing a decent growth score. This is a good combination! This makes MND very considerable for value investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

MND had positive earnings in the past year.
In the past year MND had a positive cash flow from operations.
MND had positive earnings in each of the past 5 years.
In the past 5 years MND always reported a positive cash flow from operatings.
MND.CA Yearly Net Income VS EBIT VS OCF VS FCFMND.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 15.21%, MND belongs to the top of the industry, outperforming 95.28% of the companies in the same industry.
Looking at the Return On Equity, with a value of 22.08%, MND belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
MND has a Return On Invested Capital of 19.39%. This is amongst the best in the industry. MND outperforms 97.89% of its industry peers.
MND had an Average Return On Invested Capital over the past 3 years of 11.24%. This is in line with the industry average of 12.37%.
The last Return On Invested Capital (19.39%) for MND is above the 3 year average (11.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 15.21%
ROE 22.08%
ROIC 19.39%
ROA(3y)8.49%
ROA(5y)9.17%
ROE(3y)12.53%
ROE(5y)15.1%
ROIC(3y)11.24%
ROIC(5y)13.24%
MND.CA Yearly ROA, ROE, ROICMND.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

MND has a Profit Margin of 21.54%. This is amongst the best in the industry. MND outperforms 95.90% of its industry peers.
MND's Profit Margin has declined in the last couple of years.
MND has a better Operating Margin (37.25%) than 96.52% of its industry peers.
In the last couple of years the Operating Margin of MND has grown nicely.
Looking at the Gross Margin, with a value of 43.15%, MND belongs to the top of the industry, outperforming 94.41% of the companies in the same industry.
MND's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 37.25%
PM (TTM) 21.54%
GM 43.15%
OM growth 3Y3.55%
OM growth 5YN/A
PM growth 3Y-6.05%
PM growth 5YN/A
GM growth 3Y2.91%
GM growth 5YN/A
MND.CA Yearly Profit, Operating, Gross MarginsMND.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

7

2. Health

2.1 Basic Checks

MND has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MND has been increased compared to 1 year ago.
The number of shares outstanding for MND has been increased compared to 5 years ago.
The debt/assets ratio for MND has been reduced compared to a year ago.
MND.CA Yearly Shares OutstandingMND.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MND.CA Yearly Total Debt VS Total AssetsMND.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MND has an Altman-Z score of 3.80. This indicates that MND is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MND (3.80) is better than 61.99% of its industry peers.
The Debt to FCF ratio of MND is 0.12, which is an excellent value as it means it would take MND, only 0.12 years of fcf income to pay off all of its debts.
MND has a better Debt to FCF ratio (0.12) than 96.89% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that MND is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, MND is in line with its industry, outperforming 46.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.12
Altman-Z 3.8
ROIC/WACC2.23
WACC8.69%
MND.CA Yearly LT Debt VS Equity VS FCFMND.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 2.32 indicates that MND has no problem at all paying its short term obligations.
MND's Current ratio of 2.32 is in line compared to the rest of the industry. MND outperforms 57.89% of its industry peers.
MND has a Quick Ratio of 1.93. This is a normal value and indicates that MND is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.93, MND is in line with its industry, outperforming 57.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.93
MND.CA Yearly Current Assets VS Current LiabilitesMND.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 370.59% over the past year.
The Earnings Per Share has been growing by 8.42% on average over the past years. This is quite good.
MND shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.99%.
The Revenue has been growing by 17.42% on average over the past years. This is quite good.
EPS 1Y (TTM)370.59%
EPS 3Y8.42%
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)40.99%
Revenue growth 3Y1.61%
Revenue growth 5Y17.42%
Sales Q2Q%40.63%

3.2 Future

The Earnings Per Share is expected to decrease by -3.09% on average over the next years.
MND is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.40% yearly.
EPS Next Y2.55%
EPS Next 2Y7.23%
EPS Next 3Y-9%
EPS Next 5Y-3.09%
Revenue Next Year3.83%
Revenue Next 2Y2.87%
Revenue Next 3Y-0.49%
Revenue Next 5Y-1.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MND.CA Yearly Revenue VS EstimatesMND.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
MND.CA Yearly EPS VS EstimatesMND.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 -1

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.18, the valuation of MND can be described as very cheap.
Based on the Price/Earnings ratio, MND is valued cheaply inside the industry as 98.01% of the companies are valued more expensively.
MND is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
MND is valuated cheaply with a Price/Forward Earnings ratio of 4.49.
96.77% of the companies in the same industry are more expensive than MND, based on the Price/Forward Earnings ratio.
MND's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 4.18
Fwd PE 4.49
MND.CA Price Earnings VS Forward Price EarningsMND.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MND indicates a rather cheap valuation: MND is cheaper than 99.38% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MND indicates a rather cheap valuation: MND is cheaper than 98.63% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.04
EV/EBITDA 1.79
MND.CA Per share dataMND.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of MND may justify a higher PE ratio.
MND's earnings are expected to decrease with -9.00% in the coming years. This may justify a cheaper valuation.
PEG (NY)1.64
PEG (5Y)N/A
EPS Next 2Y7.23%
EPS Next 3Y-9%

0

5. Dividend

5.1 Amount

MND does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MANDALAY RESOURCES CORP

TSX:MND (7/11/2025, 7:00:00 PM)

4.6

+0.06 (+1.32%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06
Inst Owners49.88%
Inst Owner ChangeN/A
Ins Owners2.16%
Ins Owner ChangeN/A
Market Cap435.44M
Analysts80
Price Target7.14 (55.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.98%
Min EPS beat(2)-5.49%
Max EPS beat(2)41.44%
EPS beat(4)3
Avg EPS beat(4)58%
Min EPS beat(4)-5.49%
Max EPS beat(4)117.82%
EPS beat(8)5
Avg EPS beat(8)4.3%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.88%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)3.05%
Revenue beat(4)2
Avg Revenue beat(4)5.48%
Min Revenue beat(4)-2.25%
Max Revenue beat(4)22.41%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.25%
EPS NY rev (1m)0%
EPS NY rev (3m)14.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.09%
Valuation
Industry RankSector Rank
PE 4.18
Fwd PE 4.49
P/S 1.21
P/FCF 5.04
P/OCF 2.86
P/B 1.24
P/tB 1.24
EV/EBITDA 1.79
EPS(TTM)1.1
EY23.91%
EPS(NY)1.02
Fwd EY22.26%
FCF(TTM)0.91
FCFY19.85%
OCF(TTM)1.61
OCFY34.99%
SpS3.81
BVpS3.72
TBVpS3.72
PEG (NY)1.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.21%
ROE 22.08%
ROCE 31.66%
ROIC 19.39%
ROICexc 27.12%
ROICexgc 27.12%
OM 37.25%
PM (TTM) 21.54%
GM 43.15%
FCFM 23.96%
ROA(3y)8.49%
ROA(5y)9.17%
ROE(3y)12.53%
ROE(5y)15.1%
ROIC(3y)11.24%
ROIC(5y)13.24%
ROICexc(3y)14.44%
ROICexc(5y)16.27%
ROICexgc(3y)14.44%
ROICexgc(5y)16.27%
ROCE(3y)18.36%
ROCE(5y)21.62%
ROICexcg growth 3Y6.04%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.04%
ROICexc growth 5YN/A
OM growth 3Y3.55%
OM growth 5YN/A
PM growth 3Y-6.05%
PM growth 5YN/A
GM growth 3Y2.91%
GM growth 5YN/A
F-Score9
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.12
Debt/EBITDA 0.04
Cap/Depr 138.52%
Cap/Sales 18.28%
Interest Coverage 94.28
Cash Conversion 83.73%
Profit Quality 111.25%
Current Ratio 2.32
Quick Ratio 1.93
Altman-Z 3.8
F-Score9
WACC8.69%
ROIC/WACC2.23
Cap/Depr(3y)122.26%
Cap/Depr(5y)123.51%
Cap/Sales(3y)21.13%
Cap/Sales(5y)21.9%
Profit Quality(3y)111.23%
Profit Quality(5y)107.72%
High Growth Momentum
Growth
EPS 1Y (TTM)370.59%
EPS 3Y8.42%
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y2.55%
EPS Next 2Y7.23%
EPS Next 3Y-9%
EPS Next 5Y-3.09%
Revenue 1Y (TTM)40.99%
Revenue growth 3Y1.61%
Revenue growth 5Y17.42%
Sales Q2Q%40.63%
Revenue Next Year3.83%
Revenue Next 2Y2.87%
Revenue Next 3Y-0.49%
Revenue Next 5Y-1.4%
EBIT growth 1Y218.33%
EBIT growth 3Y5.22%
EBIT growth 5YN/A
EBIT Next Year40.08%
EBIT Next 3Y10.05%
EBIT Next 5Y1.04%
FCF growth 1Y363.77%
FCF growth 3Y69.59%
FCF growth 5YN/A
OCF growth 1Y112.12%
OCF growth 3Y22.03%
OCF growth 5Y71.54%